Page last updated: 2024-09-04

febuxostat and Acute Disease

febuxostat has been researched along with Acute Disease in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	4 (66.67)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Huang, X; Li, ZL; Ma, KL; Tang, DH; Wang, CY; Ye, YS; Yi, HK; Zhang, JW	1
Chen, H; Jiang, L; Kong, X; Ma, L; Sun, Y; Zhang, X; Zhang, Z; Zhou, J; Zhou, Y	1
Carroll, MB; Shaak, TL; Smith, DM	1
Lioté, F; Perez-Ruiz, F; Scavulli, J; Terkeltaub, R; Zelman, D	1
Schlesinger, N	1
Graser, E; Pope, RS; Zychowicz, ME	1

Reviews

1 review(s) available for febuxostat and Acute Disease

Article	Year
New agents for the treatment of gout and hyperuricemia: febuxostat, puricase, and beyond. Current rheumatology reports, 2010, Volume: 12, Issue:2 Topics: Acute Disease; Chronic Disease; Colchicine; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Polyethylene Glycols; Thiazoles; Urate Oxidase	2010

Trials

1 trial(s) available for febuxostat and Acute Disease

Article	Year
New urate depositions on dual-energy computed tomography in gouty arthritis during urate-lowering therapy. Rheumatology international, 2017, Volume: 37, Issue:8 Topics: Acute Disease; Adult; Allopurinol; Arthritis, Gouty; Biomarkers; C-Reactive Protein; Febuxostat; Female; Foot Joints; Gout Suppressants; Humans; Male; Middle Aged; Statistics, Nonparametric; Tomography, X-Ray Computed; Uric Acid	2017

Other Studies

4 other study(ies) available for febuxostat and Acute Disease

Article	Year
Inosine induces acute hyperuricaemia in rhesus monkey ( Pharmaceutical biology, 2021, Volume: 59, Issue:1 Topics: Acute Disease; Allopurinol; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Febuxostat; Hyperuricemia; Imino Furanoses; Inosine; Macaca mulatta; Male; Pyrimidinones; Reproducibility of Results; Uric Acid	2021
Genomic sequencing of uric acid metabolizing and clearing genes in relationship to xanthine oxidase inhibitor dose. Rheumatology international, 2017, Volume: 37, Issue:3 Topics: Acute Disease; Aged; Allopurinol; Cohort Studies; Febuxostat; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Sequence Analysis, DNA; Uric Acid; Xanthine Oxidase	2017
Gout Study Group: update on hyperuricemia and gout. Joint bone spine, 2009, Volume: 76, Issue:4 Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Diet; Europe; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Life Style; Prednisone; Prevalence; Thiazoles; United States; Uric Acid	2009
The current state of care in gout: Addressing the need for better understanding of an ancient disease. Journal of the American Academy of Nurse Practitioners, 2010, Volume: 22 Suppl 1 Topics: Acute Disease; Aged; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Arthritis, Rheumatoid; Chronic Disease; Colchicine; Comorbidity; Disease Progression; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Patient Education as Topic; Quality of Life; Risk Factors; Thiazoles; Uric Acid; Uricosuric Agents; Xanthine Oxidase	2010